Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30026886HIVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS30026887HIVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS30026888HIVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS20037422HPVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS20047823HPVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS20067207HPVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TVIS20048431HPVENSG00000135766.9protein_codingEGLN1NoNo54583Q9GZT9
R4SCQ0
TCGA Plot Options
Drug Information
GeneEGLN1
DrugBank IDDB04847
Drug NameRoxadustat
Target IDBE0002217
UniProt IDQ9GZT9
Regulation Typeinhibitor
PubMed IDs30805897
CitationsDhillon S: Roxadustat: First Global Approval. Drugs. 2019 Apr;79(5):563-572. doi: 10.1007/s40265-019-01077-1.
GroupsApproved; Investigational
Direct ClassificationN-acyl-alpha amino acids
SMILESCC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2
Pathways
PharmGKB
ChEMBLCHEMBL2338329